Mr. McCourt joined Acceleron’s board of directors in 2016. He has 30 years of experience building commercial strategies and capabilities for new therapies at multiple pharma and biotech companies. Mr. McCourt serves as the chief commercial officer and senior vice president of marketing and sales at Ironwood Pharmaceuticals, Inc., where he led the commercial launch of LINZESS®. Prior to joining Ironwood in 2009, Mr. McCourt oversaw the U.S. brand team for denosumab at Amgen Inc. Before that, he held a number of senior commercial roles at Novartis AG, where he directed the launch and growth of ZELNORM®. He was also vice president of strategic marketing and operations during his tenure at Novartis AG.
Earlier in his career, Mr. McCourt was part of the founding team at Astra Merck Inc., leading the development of the medical affairs and science liaison group and serving as brand manager for PRILOSEC® and NEXIUM®. He earned a degree in pharmacy from the University of Wisconsin, where he serves as a member of the Board of Visitors for the School of Pharmacy.